156 related articles for article (PubMed ID: 38091158)
1. Incidence of venous thromboembolism and predictive ability of age-adjusted international prognostic index for prediction of venous thromboembolism in Asian patients with diffuse large B-cell lymphoma.
Hantrakun N; Phinyo P; Tantiworawit A; Rattarittamrong E; Chai-Adisaksopha C; Rattanathammethee T; Hantrakool S; Piriyakhuntorn P; Punnachet T; Niprapan P; Norasetthada L
J Thromb Thrombolysis; 2024 Mar; 57(3):473-482. PubMed ID: 38091158
[TBL] [Abstract][Full Text] [Related]
2. Venous-thromboembolism and associated health care utilization in elderly patients with diffuse large B cell lymphoma.
Gangaraju R; Davis ES; Bhatia S; Kenzik KM
Cancer; 2022 Jun; 128(12):2348-2357. PubMed ID: 35363373
[TBL] [Abstract][Full Text] [Related]
3. Mean platelet volume as a predictive marker for venous thromboembolism and mortality in patients treated for diffuse large B-cell lymphoma.
Rupa-Matysek J; Gil L; Kroll-Balcerzak R; Barańska M; Komarnicki M
Hematol Oncol; 2017 Dec; 35(4):456-464. PubMed ID: 27377517
[TBL] [Abstract][Full Text] [Related]
4. Incidence and risk factors for developing venous thromboembolism in Japanese with diffuse large b-cell lymphoma.
Yokoyama K; Murata M; Ikeda Y; Okamoto S
Thromb Res; 2012 Jul; 130(1):7-11. PubMed ID: 22000981
[TBL] [Abstract][Full Text] [Related]
5. Incidence of venous thromboembolism in patients with diffuse large B-cell lymphoma.
Borg IH; Bendtsen MD; Bøgsted M; Madsen J; Severinsen MT
Leuk Lymphoma; 2016 Dec; 57(12):2771-2776. PubMed ID: 27266904
[TBL] [Abstract][Full Text] [Related]
6. Incidence of venous thromboembolism in patients with non-Hodgkin lymphoma.
Sanfilippo KM; Wang TF; Gage BF; Luo S; Riedell P; Carson KR
Thromb Res; 2016 Jul; 143():86-90. PubMed ID: 27208462
[TBL] [Abstract][Full Text] [Related]
7. Prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies: validation of the Khorana Risk Score.
Rupa-Matysek J; Gil L; Kaźmierczak M; Barańska M; Komarnicki M
Med Oncol; 2017 Dec; 35(1):5. PubMed ID: 29209847
[TBL] [Abstract][Full Text] [Related]
8. Cross-sectional Study of Patients with Diffuse Large B-Cell Lymphoma: Assessing the Effect of Host Status, Tumor Burden, and Inflammatory Activity on Venous Thromboembolism.
Lim SH; Woo SY; Kim S; Ko YH; Kim WS; Kim SJ
Cancer Res Treat; 2016 Jan; 48(1):312-21. PubMed ID: 25761485
[TBL] [Abstract][Full Text] [Related]
9. The Application of the ThroLy Risk Assessment Model to Predict Venous Thromboembolism in Patients with Diffuse Large B-Cell Lymphoma.
Abdel-Razeq H; Ma'koseh M; Mansour A; Bater R; Amarin R; Abufara A; Halahleh K; Manassra M; Alrwashdeh M; Almomani M; Zmaily M
Clin Appl Thromb Hemost; 2021; 27():10760296211045908. PubMed ID: 34590497
[TBL] [Abstract][Full Text] [Related]
10. Venous thromboembolism in patients with diffuse large B-cell lymphoma.
Komrokji RS; Uppal NP; Khorana AA; Lyman GH; Kaplan KL; Fisher RI; Francis CW
Leuk Lymphoma; 2006 Jun; 47(6):1029-33. PubMed ID: 16840193
[TBL] [Abstract][Full Text] [Related]
11. Aggressive lymphoma subtype is a risk factor for venous thrombosis. Development of lymphoma - specific venous thrombosis prediction models.
Dharmavaram G; Cao S; Sundaram S; Ayyappan S; Boughan K; Gallogly M; Malek E; Metheny L; Tomlinson B; Otegbeye F; Lazarus HM; Cooper B; Fu P; de Lima M; Caimi PF
Am J Hematol; 2020 Aug; 95(8):918-926. PubMed ID: 32311162
[TBL] [Abstract][Full Text] [Related]
12. Increased risk of venous thromboembolism in patients with bullous pemphigoid. The INVENTEP (INcidence of VENous ThromboEmbolism in bullous Pemphigoid) study.
Cugno M; Marzano AV; Bucciarelli P; Balice Y; Cianchini G; Quaglino P; Calzavara Pinton P; Caproni M; Alaibac M; De Simone C; Patrizi A; Cozzani E; Papini M; Tedeschi A; Berti E; Rosendaal FR;
Thromb Haemost; 2016 Jan; 115(1):193-9. PubMed ID: 26245987
[TBL] [Abstract][Full Text] [Related]
13. Incidence and characteristics of venous thromboembolism in Asian patients with primary central nervous system lymphoma undergoing chemotherapy.
Byun JM; Hong J; Yoon SS; Koh Y; Ock CY; Kim TM; Lee JH; Kim SH; Lee JO; Bang SM; Yhim HY; Bae SH; Mun YC; Oh D;
Thromb Res; 2019 Nov; 183():131-135. PubMed ID: 31677593
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapeutic intensity and survival differences in young patients with diffuse large B-cell lymphoma: a Swedish Lymphoma Registry study.
Melén CM; Enblad G; Sonnevi K; Junlén HR; Smedby KE; Jerkeman M; Wahlin BE
Br J Haematol; 2016 Nov; 175(4):614-622. PubMed ID: 27790699
[TBL] [Abstract][Full Text] [Related]
15. Diffuse large B-cell lymphoma.
Martelli M; Ferreri AJ; Agostinelli C; Di Rocco A; Pfreundschuh M; Pileri SA
Crit Rev Oncol Hematol; 2013 Aug; 87(2):146-71. PubMed ID: 23375551
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the ThroLy score for the prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies in clinical practice.
Rupa-Matysek J; Brzeźniakiewicz-Janus K; Gil L; Krasiński Z; Komarnicki M
Cancer Med; 2018 Jul; 7(7):2868-2875. PubMed ID: 29761831
[TBL] [Abstract][Full Text] [Related]
17. Incidence of venous thromboembolism in patients with peripheral arterial disease after endovascular intervention.
Kindell DG; Marulanda K; Caruso DM; Duchesneau E; Agala C; Farber M; Marston WA; McGinigle KL
J Vasc Surg Venous Lymphat Disord; 2023 Jan; 11(1):61-69. PubMed ID: 36182086
[TBL] [Abstract][Full Text] [Related]
18. Clinical prognostic factors of diffuse large B cell non-Hodgkin lymphoma: a retrospective study.
Abdelhamid T; Samra M; Ramadan H; Mehessin M; Mokhtar N
J Egypt Natl Canc Inst; 2011 Mar; 23(1):17-24. PubMed ID: 22099932
[TBL] [Abstract][Full Text] [Related]
19. Risk factors and prognostic impact of venous thromboembolism in Asian patients with non-small cell lung cancer.
Lee YG; Kim I; Lee E; Bang SM; Kang CH; Kim YT; Kim HJ; Wu HG; Kim YW; Kim TM; Lee KW; Lee SH; Kim DW; Heo DS
Thromb Haemost; 2014 Jun; 111(6):1112-20. PubMed ID: 24477503
[TBL] [Abstract][Full Text] [Related]
20. A retrospective study of venous thromboembolism in acute leukemia patients treated at the University of Texas MD Anderson Cancer Center.
Vu K; Luong NV; Hubbard J; Zalpour A; Faderl S; Thomas DA; Yang D; Kantarjian H; Kroll MH
Cancer Med; 2015 Jan; 4(1):27-35. PubMed ID: 25487644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
